MedicaidPrior AuthHigh impact
Monjuvi® (tafasitamab-cxix) (New)
Humana·LA · Oncology, Hematology·Medicaid
We identified it
Jul 21, 2026
Summary
Humana has issued a new Prior Authorization policy for Monjuvi® (tafasitamab-cxix) affecting Louisiana Medicaid members. This is a brand-new policy (1 day old) requiring authorization before treatment. The billing team must implement prior auth procedures immediately to prevent claim denials.
Action Required
Immediately: Billing team must update the billing system to require prior authorization for Monjuvi® (tafasitamab-cxix, HCPCS code J9349) for all Louisiana Medicaid members. Before submitting any Monjuvi® claims, obtain prior authorization from Humana Louisiana Medicaid using the documented requirements from the policy. Update encounter forms and provider templates to flag Monjuvi® infusions for mandatory pre-authorization. Communicate with oncology providers that no Monjuvi® claims will be processed without prior auth approval. Failure to obtain prior authorization will result in claim denials and potential patient billing issues.